BBK Worldwide Blog

Clinical Trial Innovation: More Important Now Than Ever

A new survey gives voice to the healthcare consumer in the wake of COVID-19 and highlights the importance of innovation in clinical trial patient enrollment and engagement.

DOWNLOAD NOW

New data provides clinical trial sponsors with the information they need to confidently embrace innovative solutions in response to COVID-19. The Study Voices 2020* survey reflects perspectives from patients, medical professionals, and members of the pharmaceutical industry. The findings reveal shifts in attitudes and behaviors since the onset of COVID-19 – insight that clinical trial sponsors can leverage for enrollment and engagement efforts, including for hybrid and virtual study models.

Earlier this week, Elizabeth Gargill went one-on-one with Outsourcing-Pharma, discussing findings from BBK's recent Study Voices survey that reveal shifts in healthcare consumer attitudes and behaviors since the onset of COVID-19. In this in-depth interview, Elizabeth discusses why clinical trial innovation is more important now than ever before and how clinical trial sponsors can leverage the survey findings to enhance their enrollment and engagement efforts.

During the last two weeks of August we surveyed more than 1,200 healthcare consumers, medical professionals, and members of the pharmaceutical industry for their perspectives on topics impacting today's healthcare consumer.

The findings provide a unique look at current attitudes and behaviors that inform the patient experience. They provide clinical trial sponsors with a snapshot of a critical moment in time when we're seeing the rise of telehealth, the adoption of decentralized and hybrid trials, and heightened awareness of clinical research. They also reveal new opportunities and challenges ahead for clinical trial enrollment and engagement.

Survey Results Empower Clinical Trial Sponsors with New Opportunities for Patient Engagement

Our latest "Study Voices" survey challenges the long-held belief that the clinical trial experience should be approached differently than the healthcare consumer experience. The latest “Study Voices” survey – part of an ongoing series of surveys designed to shed light on key clinical research trends – explores patient attitudes towards technology,  healthcare affordability, physician access, transparency, and quality of care. It features responses from 2,067 individuals – 63% of whom identify themselves as healthcare consumers and 38% of whom identify themselves as clinical trial participants. The research was spearheaded by BBK's MythBusters team of Aaron Fleishman, Matt Kibby, Jessica Kim, Maddy Johnson and Elizabeth Gargill.